Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Paingone is a healthcare company specializing in non-invasive, drug-free pain management solutions through advanced medical devices. The company is best known for its portable Transcutaneous Electrical Nerve Stimulation (TENS) technology, including the original Paingone pen and the automatic Paingone Plus. These devices are designed to provide rapid relief for various conditions such as arthritis, sciatica, and musculoskeletal pain by stimulating nerves to block pain signals and trigger the body's natural endorphin release. Paingone's portfolio has expanded to include specialized products like the Aegis for back pain, the Fllow for leg circulation, and the Qalm for migraine relief. Their products are clinically tested, Class IIa medical devices, and are widely available as over-the-counter solutions globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Paingone.